Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells
about
HIV-1 Tat protein enhances microtubule polymerizationInteraction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cellsInhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesHIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox stateMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationActivation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' endThe simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivoTranscriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core ProteinTat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression.Molecular pathways in virus-induced cytokine production.Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytesTransactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic miceRecombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation.Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism.HIV-1 Nef increases T cell activation in a stimulus-dependent manner.HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialEffect of latent human immunodeficiency virus infection on cell surface phenotypeInhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivationSequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies.T-Cell Signaling in HIV-1 Infection.Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice.Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene.
P2860
Q21093229-3E85BD2C-27D0-4480-94E0-BD28975C9DCFQ21245111-696C27D4-2C86-4E19-AE1E-F1A9416224B7Q24568329-F1288638-E9E4-4543-9E02-ABDC9F5EB8A5Q24568360-A5DDB384-310E-44EE-9ED8-7C8CD8AA0A72Q24619923-09396FFC-89E4-4A79-B8B0-94B8B1BF8944Q24681560-A38D332B-236E-462A-9D36-59178512DB3CQ24682560-E0E8F89D-E387-4645-98FF-0F4E8EF00C9AQ24807291-6479712A-D54E-4C35-ACE9-66BD8F880EEAQ27317391-40A8EA3F-1439-4668-A995-40EAE4995F7CQ27469762-96E10A6D-D165-423C-80B7-980190E95C62Q33785321-350D2A69-1850-48D8-89A5-160484C5EFBFQ33795939-8480FA62-DB61-41F2-A023-2E40BD1557DAQ33797102-965212EB-386C-412F-AE58-71A391BE91BCQ33799971-B812DDC0-A72D-4620-9563-A15AC5C67E17Q33808225-48103B68-2083-47E9-9D17-B2435629063FQ34174972-8BD2A17C-30C1-415E-9AE6-34DA5B9E7799Q34425378-0CAC8501-2881-46DC-A560-23367EA4891DQ35024694-E7C82FEA-5705-4239-9989-8961CC1CAED2Q35040673-F2841472-B21E-498C-BBEA-4F8A7B0FB43DQ35668299-57B2E356-A118-4658-A104-263B52184A38Q35851955-5D91F7B3-1BDE-475E-BB4E-12D949551FF1Q35866513-21E97DFE-BB58-4E22-AB2B-B31883C8BF68Q35879801-34D41D86-F065-4163-81DA-2EF894155AECQ35883328-26FC2F3A-156D-4387-9121-48F6704DBF14Q35895488-C4A6AD3E-E02D-4BA4-9082-BE2B60291FE7Q36400607-71D38BD3-8E63-4029-BD40-A7E75F6E18BCQ36418014-9BE4349C-4179-46BE-A9B2-9149274778FFQ36986644-CD1BF854-AC9C-4DFF-B898-D1802D79A8D6Q39682575-BE1B6AB7-7F52-49C0-8A6F-0F1579FF270FQ39880793-06F0B26D-B5F7-41AD-8803-73078E4A01D1Q40004324-75749C46-A2D7-4AE2-8168-B19B32FF0E44Q40273841-586789CC-F951-4773-A8C8-EEDB11623E53Q41818257-76A29B00-CC3C-41AD-92AF-1BBAB6B5ADC1Q42273481-91108269-7AED-4049-8F9E-2CE0E4A17A3DQ42791604-FFF6DA88-DB89-45E9-AA6B-F3D360CE6CACQ42856892-1E06555C-1364-4AC1-BCE1-AF4E0075E1A6
P2860
Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human immunodeficiency virus t ...... secretion in activated T cells
@ast
Human immunodeficiency virus t ...... secretion in activated T cells
@en
Human immunodeficiency virus t ...... secretion in activated T cells
@nl
type
label
Human immunodeficiency virus t ...... secretion in activated T cells
@ast
Human immunodeficiency virus t ...... secretion in activated T cells
@en
Human immunodeficiency virus t ...... secretion in activated T cells
@nl
prefLabel
Human immunodeficiency virus t ...... secretion in activated T cells
@ast
Human immunodeficiency virus t ...... secretion in activated T cells
@en
Human immunodeficiency virus t ...... secretion in activated T cells
@nl
P2093
P2860
P3181
P1433
P1476
Human immunodeficiency virus t ...... secretion in activated T cells
@en
P2093
Krammer PH
Li-Weber M
Westendorp MO
P2860
P304
P3181
P407
P577
1994-07-01T00:00:00Z